VRFCAT Approved for FDA Program

VeriSci’s Virtual Reality Functional Capacity Assessment Tool (VRFCAT) has been accepted into the FDA’s Clinical Outcome Assessment Qualification Program. “This FDA program is intended to qualify drug development tools that can be relied on to have a specific interpretation and application in any drug development program and regulatory review.” 

We were happy to perform development on this important project! Read the press release.